CASC3 and neoplasm: Biodistribution analyses (Fig. 5a–c) demonstrated that i.p. administered BTZ does breach the BBB and could be detected in greater concentrations in tumour tissue, and from animals killed at earlier time points (P < 0.01, Fig. 5d).